RDi USA Inc. Launches at ADLM 2026, Bringing Automated Diagnostic Kitting and Connected Self-Sampling Pathways to the U.S.
New U.S. business combines automated diagnostic kit manufacturing, fulfillment, logistics and digital pathway technology to help laboratories and healthcare organizations scale testing programs.
RDi today announced the launch of RDi USA Inc. at the ADLM 2026 Clinical Lab Expo, where the new U.S. business will make its official industry debut at Booth #4454 from July 28–30.
RDi USA has been created to help laboratories, diagnostic manufacturers, healthcare providers, screening organizations and research partners overcome one of the largest barriers to scaling diagnostic testing: the fragmented infrastructure surrounding the test itself, for partners operating across complex and high-volume testing environments.
The company brings together kit design, component sourcing, automated assembly, fulfillment, sample-return logistics, laboratory integration and digital engagement within one connected operating model.
